• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Perrigo Company

Perrigo Company

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Global Animal Pharmaceuticals Market to Grow at a CAGR of 7.7%, 2016-2022 With Merck, Vetoquinol, Zoetis, Virbac, Boehringer Ingelheim, Perrigo Company & Eli Lilly and Company Leading - Research and ...

    Global Animal Pharmaceuticals Market to Grow at a CAGR of 7.7%, 2016-2022 With Merck, Vetoquinol, Zoetis, Virbac, Boehringer Ingelheim, Perrigo Company & Eli Lilly and Company Leading - Research and Markets

  2. UPDATE: U.S. stocks struggle to resume record run as traders wait for Trump's speech

    UPDATE: U.S. stocks struggle to resume record run as traders wait for Trump's speech

  3. UPDATE: Stocks retreat as investors await big Trump speech

    UPDATE: Stocks retreat as investors await big Trump speech

  4. Perrigo shares down 9% after company reports loss, sells drug royalties

    Perrigo shares down 9% after company reports loss, sells drug royalties

  5. Ultimate Stock-Pickers: 10 High-Conviction and New-Money Purchases

    The continuing U.S. stock market rally has diminished the number and similarity of purchases across these top managers.

  6. A Shift in Health-Care M&A Activity

    Recent deals have been driven more by tax strategies than therapeutic synergies.

  7. Heightened Deal Activity Puts Merger-Arbitrage ETFs in Spotlight

    Favorable conditions are in place for merger-arbitrage ETFs, including increasing M&A activity and the likelihood of higher interest rates.

©2017 Morningstar Advisor. All right reserved.